Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -17690.19% is 352% below its 5-year average of -3910.66%, near the low end of its 5-year range (-17690.19%–0.00%).
181.17% below its 12-month average of -6291.68%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -1532.31%.
NET PROFIT MARGIN
-17690.19%
NET PROFIT MARGIN AVG TTM
-6291.68%
NET PROFIT MARGIN AVG 3Y
-3387.49%
NET PROFIT MARGIN AVG 5Y
-3910.66%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-181.17%
CURRENT VS 3Y AVG
-422.22%
CURRENT VS 5Y AVG
-352.36%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 764 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Akanda Corp.
Market Cap
$61819.00
Net Profit Margin
-17690.19%
TTM Avg
-6291.68%
3Y Avg
-3387.49%
5Y Avg
-3910.66%
Market Cap
$71496.00
Net Profit Margin
-22521.52%
TTM Avg
-14229.41%
3Y Avg
-9670.52%
5Y Avg
-6447.01%
Market Cap
$30509.00
Net Profit Margin
-44.25%
TTM Avg
-77.97%
3Y Avg
-46.13%
5Y Avg
-41.70%
Market Cap
$95000.00
Net Profit Margin
N/A
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$109442.00
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$6210.00
Net Profit Margin
N/A
TTM Avg
99.68%
3Y Avg
52.40%
5Y Avg
41.92%
Market Cap
$244081.00
Net Profit Margin
-1422.78%
TTM Avg
-951.97%
3Y Avg
-568.57%
5Y Avg
-575.76%
Market Cap
$389228.00
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
-352.76%
5Y Avg
-376.69%
Market Cap
$559702.00
Net Profit Margin
-73.22%
TTM Avg
-7923.42%
3Y Avg
-4237.01%
5Y Avg
-2848.17%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Akanda Corp. (AKAN) | $61819.00 | -17690.19% | -6291.68% | -3387.49% | -3910.66% |
| PRF Technologies Ltd. (PRFX)vs › | $71496.00 | -22521.52% | -14229.41% | -9670.52% | -6447.01% |
| Mobile-health Network Solutions Class A Ordinary Shares (MNDR)vs › | $30509.00 | -44.25% | -77.97% | -46.13% | -41.70% |
| Psyence Biomedical Ltd. (PBM)vs › | $95000.00 | N/A | 0.00% | 0.00% | 0.00% |
| Silexion Therapeutics Ltd. (SLXN)vs › | $109442.00 | 0.00% | 0.00% | 0.00% | 0.00% |
| NewGenIvf Group Limited (NIVF)vs › | $6210.00 | N/A | 99.68% | 52.40% | 41.92% |
| SciSparc Ltd. (SPRC)vs › | $244081.00 | -1422.78% | -951.97% | -568.57% | -575.76% |
| Niki BioSolutions, Inc. (NIKI)vs › | $389228.00 | 0.00% | 0.00% | -352.76% | -376.69% |
| HCW Biologics Inc. (HCWB)vs › | $559702.00 | -73.22% | -7923.42% | -4237.01% | -2848.17% |
| CDT Equity Inc. (CDT)vs › | $685948.00 | 6.30% | 0.00% | 0.00% | 0.00% |
Operating Margin
-1931.0%
Net Profit Margin
-17690.2%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -1532.31% |
| 2025-12-31 | -17342.73% |
| 2025-06-30 | 0.00% |
| 2024-12-31 | -392.91% |
| 2024-06-30 | -562.44% |
| 2023-12-31 | -3461.44% |
| 2023-06-30 | -420.62% |
| 2022-12-31 | -355.92% |
| 2022-06-30 | -3548.41% |
| 2021-12-31 | -11678.68% |
| 2021-06-30 | -3721.81% |
| 2020-12-31 | 213656.57% |
| 2020-06-30 | -197505.03% |
| 2019-12-31 | 0.00% |
| 2019-06-30 | 0.00% |
